drugset / Trial / NCT00422578

Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction

NCT00422578

Phase 4 Completed 200 enrolled Eli Lilly and Company ICOS Corporation · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Study is a clinical study assessing the effect of oral tadalafil 10mg or 20 mg on psychosocial aspects and quality of life of erectile dysfunction patients and to compare tadalafil with previous oral erectile dysfunction medication. Study period is 13 weeks. Study patients fill in quality of life questionnaires and treatment satisfaction questionnaires.

Timeline

Start
2004-10
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 10 mg Oral
Subject Tadalafil Small molecule 20 mg Oral

Indications